Z-0514-2016 Class III Terminated
FDA device recall Z-0514-2016 was initiated by Ameditech Inc on Nov 16, 2015 and is designated Class III. Reason for recall: Ameditechs Drugs of Abuse Tests listed above have shown reduced reactivity for up to two (2) of the nineteen (19) Benzodiazepine (BZO) compounds for which specificity information is provided in the… The recall status is terminated (terminated Nov 9, 2016). Affected quantity: 4,646 kits.
Recall details
- Product Type
- Devices
- Report Date
- Dec 30, 2015
- Initiation Date
- Nov 16, 2015
- Termination Date
- Nov 9, 2016
- Voluntary/Mandated
- Voluntary: Firm initiated
- Product Quantity
- 4,646 kits
Product description
Micro Screen 6 Panel Cup with Adult (AU), Item No. MSCA-6MBAU
Reason for recall
Ameditechs Drugs of Abuse Tests listed above have shown reduced reactivity for up to two (2) of the nineteen (19) Benzodiazepine (BZO) compounds for which specificity information is provided in the product insert. The particular BZO compounds for which there may be reduced reactivity are Clonazepam and Chlordiazepoxide.
Distribution pattern
Nationwide Distribution.
Code information
G140256 G140281 G140307 G140340 G140418 G140419 G150135 G150141 G150187 G150257
Source
- Dataset
- openFDA device recall enforcement reports
- FDA record
- This recall in openFDA (JSON)
- Enforcement Report
- Search FDA's Enforcement Report for Z-0514-2016
- openFDA file date
- Nov 16, 2026
- Loaded by RegDataLab
- Nov 17, 2026